244 related articles for article (PubMed ID: 3179762)
1. [Use of radioimmunoanalysis of tumor markers in the diagnosis of carcinoma of the breast, ovary and intestines].
Kausitz J
Bratisl Lek Listy; 1988 Aug; 89(8):563-76. PubMed ID: 3179762
[No Abstract] [Full Text] [Related]
2. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
[TBL] [Abstract][Full Text] [Related]
3. [Tumor markers: new prospects in the diagnosis and clinical monitoring of malignant epithelial neoplasms of the ovary].
Gadducci A; Ferdeghini M; Prato B; Bartolini T; Nicolini A; Scatena P; Facchini V; Bianchi R; Fioretti P
Ann Ostet Ginecol Med Perinat; 1985; 106(1):34-9. PubMed ID: 2994537
[No Abstract] [Full Text] [Related]
4. [Tumor markers in ovarian cancer].
Lahousen M
Jugosl Ginekol Perinatol; 1987; 27(3-4):73-5. PubMed ID: 3481005
[No Abstract] [Full Text] [Related]
5. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744
[No Abstract] [Full Text] [Related]
6. [Tissue polypeptide antigen in breast cancer].
Nomizu T; Watanabe I; Endo S
Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2287-95. PubMed ID: 6085339
[No Abstract] [Full Text] [Related]
7. [Ovarian cancer--a comparison between CT diagnosis and serum tumor markers].
Wakabayashi Y; Yachida M; Akata S; Kawana K; Kotake F; Kakizaki D; Abe K; Negishi N; Akiya K
Gan No Rinsho; 1988 Jan; 34(1):52-6. PubMed ID: 3422324
[TBL] [Abstract][Full Text] [Related]
8. Sialyl-Tn, sialyl-Lewis Xi, CA 19-9, CA 125, carcinoembryonic antigen, and tissue polypeptide antigen in differentiating ovarian cancer from benign tumors.
Inoue M; Fujita M; Nakazawa A; Ogawa H; Tanizawa O
Obstet Gynecol; 1992 Mar; 79(3):434-40. PubMed ID: 1346716
[TBL] [Abstract][Full Text] [Related]
9. [Quality control of the RIA method for 3 tumor markers].
Fusco A; Ciarniello P; Latella G; Milani C; Antonucci M; Scuderi A; Giannoni MF; Caprilli R
Minerva Med; 1987 Apr; 78(7):463-4. PubMed ID: 3472102
[No Abstract] [Full Text] [Related]
10. [Tumor markers in the diagnosis of pancreatic carcinoma].
Lemma F; Bombardieri T; Salibra M; Trovato P; De Pasquale MC; Faraone V; Punturiero R; Di Mauro S
Minerva Med; 1989 Jul; 80(7):645-9. PubMed ID: 2779818
[No Abstract] [Full Text] [Related]
11. Tumor markers in the management of patients with ovarian cancer.
Tuxen MK; Sölétormos G; Dombernowsky P
Cancer Treat Rev; 1995 May; 21(3):215-45. PubMed ID: 7656266
[No Abstract] [Full Text] [Related]
12. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer.
Kausitz J; Hupka S; Makaiová I; Michalíková B; Urbanová M; Bohunický L; Belovicová C
Neoplasma; 1986; 33(4):471-6. PubMed ID: 3762808
[TBL] [Abstract][Full Text] [Related]
13. [Predictive value of a tumor marker combination for the monitoring of ovarian cancer].
Lahousen M
Wien Klin Wochenschr; 1986 May; 98(10):319-25. PubMed ID: 3460273
[TBL] [Abstract][Full Text] [Related]
14. [Biological significance of tumor marker].
Ochi Y
Rinsho Byori; 1985 Aug; 33(8):831-8. PubMed ID: 3908745
[No Abstract] [Full Text] [Related]
15. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
Kataoka A; Yakushiji M
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
[TBL] [Abstract][Full Text] [Related]
16. [Human breast cancer markers].
Remennik LV
Eksp Onkol; 1985; 7(4):3-8. PubMed ID: 2994992
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of serum sialyl Tn antigen in patients with gynecological cancer. STN Study Group].
Noda K; Shiota M; Tanizawa O; Inoue M; Tenjin Y; Sugishita T; Yakushiji M; Miyoshi T; Nozawa S; Sakuma T
Gan To Kagaku Ryoho; 1991 Jul; 18(8):1287-96. PubMed ID: 2069400
[TBL] [Abstract][Full Text] [Related]
18. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
[TBL] [Abstract][Full Text] [Related]
19. [Tissue polypeptide antigen in thyroid cancer].
Nomizu T; Watanabe I; Endo S
Nihon Gan Chiryo Gakkai Shi; 1984 Jul; 19(6):1289-95. PubMed ID: 6595323
[No Abstract] [Full Text] [Related]
20. Carcinoembryonic antigen, ferritin, tissue polypeptide antigen, and CA15/3 in breast cancer: relationship between carcinoma and normal breast tissue.
Gion M; Mione R; Dittadi R; Griggio L; Munegato G; Valsecchi M; Del Maschio O; Bruscagnin G
Int J Biol Markers; 1986; 1(1):33-8. PubMed ID: 3480322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
